CMBA
BLFS icon

C.M. Bidwell & Associates’s BioLife Solutions BLFS Stock Holding History

C.M. Bidwell & Associates’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-5,030
Closed -$30K – 389
2017
Q4 		$30K Buy
+5,030
New +$29K 0.03% 273

Other funds holding BLFS

SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KIA
Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return

C.M. Bidwell & Associates's BLFS Position: Q1 2018 in Review

C.M. Bidwell & Associates sold out of BioLife Solutions (BLFS) in Q1 2018, closing a stake of 5,030 shares — an estimated $30K sold.

C.M. Bidwell & Associates first reported a position in BLFS in Q4 2017 and held it in 1 quarter. The position peaked at $30K in Q4 2017. 30 funds tracked by Wall St. Rank hold BLFS as of Q1 2018.

  • C.M. Bidwell & Associates reported no remaining BioLife Solutions position as of Q1 2018 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 5,030 BioLife Solutions shares in Q1 2018, an estimated $30K.
  • C.M. Bidwell & Associates first reported a position in BioLife Solutions in Q4 2017 and held it in 1 quarter.
  • C.M. Bidwell & Associates's BioLife Solutions position peaked at $30K in Q4 2017.
  • 30 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2018.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2018, filed 11 May 2018.